Antagonist Peptides To The C5a Chemotactic Function Of Vitamin D Binding Protein


It has been demonstrated that one of Vitamin D Binding Protein (DBP) biological functions is to enhance the chemotactic activity of C5a and C5a des Arg. The present invention has found that peptides having sequences that substantially correspond to a specific region in the N-terminal domain I of DBP can block the DBP enhancement of C5a or C5a des Arg chemotactic activity. Based in this discovery the present invention provides DBP antagonist peptides and the use thereof for the treatment C5a or C5a des Arg-mediated disorders.

Download PDF
Document Preview
Document History
  • Publication: Jun 16, 2009
  • Application: Oct 5, 2005
    US US 24396005 A
  • Priority: Oct 5, 2005
    US US 24396005 A
  • Priority: Oct 5, 2004
    US US 61610504 P

Download Citation

Sign in to the Lens